golidocitinib
dizal pharma
['t-cell lymphoma', 'golidocitinib', 'lymphoma', 'hodgkin', 'peripheral t-cell lymphoma', 'ptcl', 'dizal']
#ash22 we were glad to present new analysis on a global phase i/ii trial of golidocitinib for the treatment of relapsed/refractory peripheral t-cell lymphoma (r/r ptcl). #ash22 #lymphoma #oncology 
Dizal is a clinical stage, biopharmaceutical company dedicated to differentiated therapeutics for the treatment of cancer and immunological diseases.